Objective: To determine the impact of prior gestational diabetes mellitus (GDM) on perinatal outcomes in a subsequent GDM pregnancy.
Methods: This retrospective cohort study included 544 multiparous patients with two consecutive pregnancies between 2012-2019, where the second (index) pregnancy was affected by GDM. The primary exposure was prior GDM diagnosis, categorized into medical and dietary management. The primary outcome was a composite including need for pharmacotherapy, large-for-gestational age, or neonatal hypoglycemia. Adjusted odds ratios (aOR) were calculated using multivariable logistic regression controlling for maternal age, pre-pregnancy body mass index, and gestational age at GDM diagnosis in the index pregnancy.
Results: Of the 544 patients, 164 (30.1%) had prior GDM. Prior GDM significantly increased the likelihood of composite outcome compared to no prior GDM (74.4% vs. 57.4%; P < 0.001). After adjusting for confounders, prior GDM remained significantly associated with the composite outcome (aOR 2.03, 95% confidence interval [CI] 1.31-3.15). Stratifying by prior GDM treatment modality, a significant association was found for prior pharmacotherapy-controlled GDM (aOR 3.29, 95% CI 1.64-6.59), but not for prior diet-controlled GDM (aOR = 1.54, 95% CI 0.92-2.60).
Conclusion: A history of pharmacotherapy-controlled GDM in a previous pregnancy increases odds of adverse perinatal outcomes in a subsequent GDM pregnancy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/ijgo.15775 | DOI Listing |
Surg Obes Relat Dis
December 2024
General Surgery Department, Bariatric Surgery Program, Hospital Privado Universitario de Córdoba, Córdoba, Argentina.
BMC Med
December 2024
Department of Obstetrics and Gynecology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
Background: Pregnancy is a complex biological process and serious complications can arise when the delicate balance between the maternal and semi-allogeneic fetal immune systems is disrupted or challenged. Gestational diabetes mellitus (GDM), pre-eclampsia, preterm birth, and low birth weight pose serious threats to maternal and fetal health. Identification of early biomarkers through an in-depth understanding of molecular mechanisms is critical for early intervention.
View Article and Find Full Text PDFAm J Obstet Gynecol
December 2024
Harris Birthright Research Centre for Fetal Medicine, Fetal Medicine Research Institute, King's College Hospital, London, UK. Electronic address:
Objective: To investigate whether nuclear magnetic resonance (NMR)-based metabolomic profiling of maternal blood can be used for first-trimester prediction of gestational diabetes mellitus (GDM).
Study Design: This was a prospective study of 20,000 women attending for routine pregnancy care at 11-13 weeks' gestation. Metabolic profiles were assessed using a high-throughput NMR metabolomics platform.
Diabetes Care
December 2024
Western Sydney University, Campbelltown, New South Wales, Australia.
Objective: To investigate the association of timing of commencing glucose management with glycemia, glycemic variability, and pregnancy outcomes among women with early gestational diabetes mellitus (GDM).
Research Design And Methods: In this substudy among participants of a trial of immediate vs delayed treatment of early GDM diagnosed by 2013 World Health Organization criteria, all women treated immediately and those with delayed diagnosis at 24-28 weeks' gestation (treated as if late GDM) were instructed to monitor capillary blood glucose (BG) four times a day (fasting and 2-h postprandial) until delivery. Optimal glycemia was defined as ≥95% of BG measurements between 70 and 140 mg/dL (3.
J Clin Endocrinol Metab
December 2024
Department of Prevention, Health Promotion & Community Care, Copenhagen University Hospital - Steno Diabetes Center Copenhagen, Herlev, Denmark.
Context: Gestational diabetes mellitus (GDM) increases the risk of future type 2 diabetes (T2DM), but effective and feasible interventions to reduce this risk are lacking.
Objective: To evaluate the effectiveness of a family-based health promotion intervention on T2DM risk factors and quality of life among women with recent GDM.
Design: Multicenter, parallel, open-label randomized controlled trial with 2:1 allocation ratio.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!